The George Institute for Global Health joins Paddington Life Sciences Partners

The George Institute for Global Health has joined Paddington Life Sciences Partners as an associate member, bringing expertise in clinical research and global health systems to the cross-sector partnership of life sciences organisations centred around St Mary’s Hospital and beyond.

Led by Imperial College Healthcare NHS Trust, Paddington Life Sciences is a collaborative initiative designed to deliver major health, social and economic value through partnerships across NHS, academia, industry and community organisations.

A global leader in health research 

With centres in the UK, Australia, China and India, The George Institute is a leading independent medical research organisation renowned for conducting large-scale clinical trials and pioneering research that addresses some of the most pressing global health challenges.

The George Institute has been a strategic partner of Imperial College London since 2020, working to drive the development and evaluation of innovative and sustainable global health systems.

The Institute is based at Imperial’s White City Campus, a rapidly emerging hub for life sciences research and innovation that forms part of the WestTech London.

Strengthening clinical trials in north west London

The George Institute has extensive experience in conducting large-scale clinical trials and establishing collaborative networks. The new partnership will explore the combined capabilities of Paddington Life Sciences and The George Institute to leverage that expertise to position north west London as a testbed for innovative trial technologies.

A key focus of the collaboration is improving diversity and inclusion in clinical trials and to co-produce strategies to ensure trials in north west London are more representative and equitable.

Professor Otavio Berwanger, executive director, The George Institute for Global Health, UK, said:

“We are excited to join the Paddington Life Sciences community as an associate member. At The George Institute for Global Health, our mission is to improve the health of millions globally, and collaboration is key to achieving that. This partnership offers a unique opportunity to work with leading organisations to address some of the most pressing health challenges of our time. Together, we can accelerate the generation of robust evidence and translate it into scalable solutions that truly improve relevant outcomes for people and communities both in the UK and worldwide.”

Dr Suki Balendra, director of strategic partnerships for Paddington Life Sciences, added: 

“We are delighted to welcome The George Institute as an associate member. Their global leadership in evidence-based research and commitment to improving health outcomes aligns perfectly with our mission to create a collaborative, place-based ecosystem that drives innovation and equity in healthcare.  We are thrilled that they are bringing their expertise in clinical trial delivery into our work, and we look forward to extending that to our wider partners.”

About Paddington Life Sciences Partners

The partnership includes leading organisations such as British Land, Brockton Everlast, Convatec, Derwent London, Imperial College Healthcare NHS Trust, Imperial College London, Ipsen, IQVIA, Microsoft, Optum, Oracle Health, Shionogi, Takeda, Vertex and Vodafone. The associate partners are: Imperial College Health Partners, Imperial Health Charity, Healthcare Central London, North West London Pathology, and The George Institute.

As an associate member, The George Institute will take on a strategic advisory role within Paddington Life Sciences Partners, contributing to shared projects across four priority areas:

  • Social value

  • Diversity and equity in clinical trials

  • Data and digital 

  • Place and space